A new study has brought great relief to breast cancer victims the world over. According to researchers in the Cancer Unit at the Kansas City Veterans Affairs Medical Center, a mere aspirin per day can greatly reduce the onset of breast cancer.
In the past, aspirin has been found to not only treat headaches and migraines, but low-grade doses of aspirin have also been found to prevent cardiac episodes and the reoccurrence of issues like heart attacks or strokes. On top of that, aspirin has been found to prevent tumor growth in prostate, gastrointestinal, and colon cancer.
Now, however, a major discovery in Kansas has revealed that aspirin can have the same effect on breast cancer. The core of the aspirin/breast cancer discovery centers around making cancer cells non-conducive for reproduction. According to the research at the Kansas Cancer Unit, Aspirin does just that in breast cancer cells.
The research study of aspirin’s effects on breast cancer were as follows. Dr. Sushanta Banerjee, the research director of the Cancer Research Center at the Kansas VA Center, and his team grew cancer cells in 96 different groups. They then exposed half of the cancer cells – such as those present in breast cancer – to various concentrations of aspirin. The experiment was an instant success. Those breast cancer cells exposed to aspirin either died at an increased rate or were unable to reproduce any further. The next step of the research was to give 20 mice infected with aggressive tumors 75 milligrams of aspirin. That amount of aspirin is a typical low-dosage concentration. The mice received the treatment for 15 days straight, and at the end fo theat time, the mice treated with the aspirin had tumors that were 50 percent smaller than the mice with untreated tumors.
As an addendum to the cancer and aspirin research, before mice were exposed to cancer cells, researchers gave a large set of mice aspirin for 10 days. The result was that the mice that were pre-treated with aspirin before being given cancer had “significantly less cancer growth” than the mice that didn’t receive a pretreatment of aspirin.
Dr. Banerjee spoke about the results published in Laboratory Investigations.
“We found aspirin caused these residual cancer cells to lose their self-renewal properties. Basically, they couldn’t grow or reproduce. So there are two parts here. We could give aspirin after chemotherapy to prevent relapse and keep the pressure on, which we saw was effective in both the laboratory and the mouse model, and we could use it preventatively.”
[Photo by Tim Boyle/Getty Images]